Phase
Condition
Dementia
Treatment
PERI-MIND
Clinical Study ID
Ages 40-58 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Female sex at birth
Aged between 40-58 years
Late perimenopause or early post-menopause
Elevated dementia risk characterized by first degree relative with diagnosis ofAlzheimer's disease or another dementia
Exclusion
Exclusion Criteria:
Diagnosis of Mild Cognitive Impairment, Alzheimer's or another dementia
Diagnosis of other chronic illness or condition that affects cognition (e.g., Axis Ipsychiatric disorders such as schizophrenia or mood disorders, neurologicaldisorders such as stroke, cancer, traumatic brain injury)
Inadequate vision or hearing to engage with intervention materials
Unable or unwilling to provide informed consent
Iatrogenic menopause (i.e., due to surgery)
Study Design
Connect with a study center
University of Chicago Medicine
Chicago, Illinois 60637
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.